The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome. Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened beverages are major risk factors for development of NAFLD. Today the most commonly consumed sugar is high fructose corn syrup. Hepatic lipids may be derived from dietary intake, esterification of plasma free fatty acids (FFA) or hepatic de novo lipogenesis (DNL). A central abnormality in NAFLD is enhanced DNL. Hepatic DNL is increased in individuals with NAFLD, while the contribution of dietary fat and plasma FFA to hepatic lipids is not significantly altered. The importance of DNL in NAFLD is further established in mouse studies with knockout of genes involved in this process. Dietary fructose increases levels of enzymes involved in DNL even more strongly than HFD. Several properties of fructose metabolism make it particularly lipogenic. Fructose is absorbed via portal vein and delivered to the liver in much higher concentrations as compared to other tissues. Fructose increases protein levels of all DNL enzymes during its conversion into triglycerides. Additionally, fructose supports lipogenesis in the setting of insulin resistance as fructose does not require insulin for its metabolism, and it directly stimulates SREBP1c, a major transcriptional regulator of DNL. Fructose also leads to ATP depletion and suppression of mitochondrial fatty acid oxidation, resulting in increased production of reactive oxygen species. Furthermore, fructose promotes ER stress and uric acid formation, additional insulin independent pathways leading to DNL. In summary, fructose metabolism supports DNL more strongly than HFD and hepatic DNL is a central abnormality in NAFLD. Disrupting fructose metabolism in the liver may provide a new therapeutic option for the treatment of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Fructose enhances its own metabolism by upregulating ketohexokinase (KHK), which is elevated in MASLD; diets high in both fat and fructose worsen MASLD, but fructose alone more strongly induces DNL enzymes like ACC1, FASN, and stearoyl-CoA desaturase 1 (SCD1) compared to HFDs [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Patients with MASLD often show reduced hepatic ATP [13].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
In the citing paper
“Importantly, DAG buildup, not TG, is linked to hepatic IR via PKC activation.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Sontrop, J. M., Dixon, S. N., Garg, A. X., Jiménez, I. B., Dohein, O., Huang, S. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,903
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Self-citationTriglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,805
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Loomba, R. S., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,732
Insulin Receptor Signaling in Normal and Insulin-Resistant StatesPreprint
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,550
Self-citation
Cited by
Sorted by citations
Items 401–500 of 705
Niu, S., Chen, S., Wu, D., Wang, C., Xu, J., Yin, J., & Zhao, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1650729 · Cited by 7
Fructose-rich diet and insulin action in female rat heart: Estradiol friend or foe?
Bundalo, M., Romić, S., Tepavčević, S., Stojiljković, M., Stanković, A., Živković, M., & Korićanac, G. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.06.003 · Cited by 7
Scheidl, T. B., Wager, J. L., Baker, L., Brightwell, A. L., Melan, K. M., Larion, S., Sarr, O., Regnault, T. R. H., Urbanski, S. J., & Thompson, J. A. (2023) · Bioscience Reports · doi:10.1042/bsr20231060 · Cited by 7
Cortez, N. E., Lanzi, C. R., Vahmani, P., Matsukuma, K. E., & Mackenzie, G. G. (2023) · Oncology Letters · doi:10.3892/ol.2023.14067 · Cited by 7
Shokri, B., Mohebbi, H., & Mehrabani, J. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02347-y · Cited by 7
Fadhul, T., Park, S., Ali, H., Alsiraj, Y., Wali, J. A., Simpson, S. J., & Softic, S. (2024) · Nutrients · doi:10.3390/nu17010124 · Cited by 7
Self-citationFructose Intake: Metabolism and Role in Diseases
He, L., Babar, G., Redel, J. M., Young, S. L., Chagas, C. E., Moore, W. V., & Yan, Y. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95754 · Cited by 7
Guan, H., Wang, Y., Li, H., Zhu, Q., Li, X., Liang, G., & Ge, R.-S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.594437 · Cited by 7
State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
Cho, Y., & Lee, Y. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.102 · Cited by 7
Mendoza-Pérez, S., García-Gómez, R. S., & Durán-Domínguez-de-Bazúa, M. D. C. (2022) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2022.2088705 · Cited by 8
Yamazaki, T., & Ihato, M. (2022) · Biomedicines · doi:10.3390/biomedicines10092199 · Cited by 7
Im, S. T., Mun, H., Park, S., Kang, H. H., Kim, W.-C., Heo, S., & Lee, S. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113864 · Cited by 7
Okrit, F., Chayanupatkul, M., Wanpiyarat, N., Siriviriyakul, P., & Werawatganon, D. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26055 · Cited by 7
Akinnuga, A. M., Siboto, A., Khumalo, B., Sibiya, N. H., Ngubane, P. S., & Khathi, A. (2020) · Cardiovascular Therapeutics · doi:10.1155/2020/1936406 · Cited by 7
Ren, T., Liu, H., Zhang, X., Zhang, P., Gao, Q., Jia, X., Xu, T., Yue, T., & Yang, Z. (2021) · Aquaculture Reports · doi:10.1016/j.aqrep.2021.100718 · Cited by 7
Paramastri, R., Hsu, C., Chuang, Y., Lee, H.-A., Wiratama, B. S., & Chao, J. C.-J. (2021) · Nutrients · doi:10.3390/nu13103591 · Cited by 7
Landgraf, A., Okada, J., Horton, M., Liu, L. P., Solomon, S., Qiu, Y., Kurland, I. J., Sidoli, S., Pessin, J. E., & Shinoda, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.15.649020 · Cited by 7
Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice
Ren, R., Wang, Q., Deng, D., Guo, A., Chen, X., Meng, Y., Ying, F., Zheng, G., Xu, Z., Li, M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1503247 · Cited by 6
Verhoeven, A., Gatzios, A., Rodrigues, R. M., Sanz-Serrano, J., Kock, J. D., Vinken, M., & Vanhaecke, T. (2025) · Toxicology · doi:10.1016/j.tox.2025.154263 · Cited by 6
Sharma, T., Kaushal, N., & Garla, R. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i8.108772 · Cited by 6
From nutrients to health outcomes: integrating diet, disease risk, and lifelong wellness
Kaushik, M., Vanangamudi, M., Sharma, S., Guptha, P. M., Surendran, V., Abubakar, M., & Nand, S. (2026) · 3 Biotech · doi:10.1007/s13205-026-04837-5 · Cited by 7
Lee, M., Park, S., Xu, Y., Kim, J.-E., Han, H., Lee, J.-H., Paik, J. K., & Lee, H. (2022) · Applied Sciences · doi:10.3390/app12136745 · Cited by 6
Fakhoury-Sayegh, N., Hamdan, A., Lebbos, S., Itani, T. M., Trak-Smayra, V. E., Khazzaka, A., Dagher‐Hamalian, C., Sayegh, L. N., Mallah, M., Obeid, O., et al. (2024) · Nutrients · doi:10.3390/nu16111701 · Cited by 6
Liu, Y., Lu, Q., Han, G., Zheng, Y., Cao, J., Xi, L., Liu, H., Jin, J., Zhang, Z., Yang, Y., et al. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102187 · Cited by 6
Feng, X., Wang, M.-Q., Wen, S., Hu, L., Lan, Y., & Xu, H. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10373-6 · Cited by 6
Mitochondrial targeted therapies in MAFLD
Lai, S., Tang, D., & Feng, J. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151498 · Cited by 10
Bloomer, S. A., Wellen, K. E., & Henderson, G. C. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0639-7 · Cited by 6
Singdam, P., Naowaboot, J., Senggunprai, L., Boonloh, K., & Pannangpetch, P. (2022) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2022.27.4.384 · Cited by 7
Mentha canadensis attenuates adiposity and hepatic steatosis in high-fat diet-induced obese mice
Han, Y., Choi, J., & Kwon, E. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.5.870 · Cited by 5
Okrit, F., Chayanupatkul, M., Siriviriyakul, P., Wanpiyarat, N., & Werawatganon, D. (2024) · Biomedicines · doi:10.3390/biomedicines12030483 · Cited by 6
Anantha, P., Wu, X., Elsaid, S., Raj, P., Hu, J., Barman, I., & Tee, S. S. (2025) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70052 · Cited by 6
Fructose use in clinical nutrition
Moulin, S., Seematter, G., & Seyssel, K. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000376 · Cited by 6
Oenothein B in Eucalyptus Leaf Extract Suppresses Fructose Absorption in Caco-2 Cells
Sugimoto, K., Amako, M., Takeuchi, H., Nakagawa, K., Yoshimura, M., Amakura, Y., Fujita, T., Takenaka, S., & Inui, H. (2021) · Molecules · doi:10.3390/molecules27010122 · Cited by 6
What Is the Optimal Dietary Composition for NAFLD?
George, E. S., Tierney, A. C., Campbell, K. L., Macdonald, G. A., & Hickman, I. J. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0373-7 · Cited by 6
Sleep disruption in nonalcoholic fatty liver disease: What is the role of lifestyle and diet?
Akram, S., Ewy, M. W., & Said, A. (2021) · PubMed · doi:10.1097/meg.0000000000002049 · Cited by 5
Hong, J., Shi, Y., Xu, F., Chen, J., Mi, M., Ren, Q., & Kang, Y. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01604 · Cited by 5
Mou, Y., Tang, Y., Zheng, X., Liu, X., Wu, X., Wang, H., Zeng, J., Rao, Q., Ben‐David, Y., Li, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1542143 · Cited by 5
Wang, X., Wang, Z., Liu, Z., Huang, F., Pan, Z., Zhang, Z., & Liu, T. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189322 · Cited by 5
Bhattacharjee, P., Fadlaoui, A., Ryan, C. E., Carlson, C. B., Zhang, D., & Sunny, N. E. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.04.030 · Cited by 5
Nutrition and Neuroinflammation: Are Middle-Aged Women in the Red Zone?
Bernier, V., Chatelan, A., Point, C., & Strauss, M. (2025) · Nutrients · doi:10.3390/nu17101607 · Cited by 6
Lim, S., Park, M.-J., Yoon, K., Lee, J., Matienzo, M. E., Hong, S., Kim, K., Baek, Y.-B., Lee, C., Kim, Y.-M., et al. (2025) · Food Chemistry X · doi:10.1016/j.fochx.2025.102679 · Cited by 5
TMAO Accumulation Induced by Hyperglycemia Triggers Endoplasmic Reticulum Stress in the Mouse Liver
Gao, Q., Li, T., AL‐Ansi, W., Fan, M., Qian, H., Li, Y., & Wang, L. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70278 · Cited by 5
Suttawong, N., Witayavanitkul, N., Chayanupatkul, M., Wanpiyarat, N., Werawatganone, P., Siriviriyakul, P., & Werawatganon, D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333800 · Cited by 5
Peres, H. A., Pereira, L. R. L., & Foss, M. C. F. (2016) · Journal of Nutrition & Food Sciences · doi:10.4172/2155-9600.1000558 · Cited by 5
Age-Dependent Skeletal Muscle Mitochondrial Response to Short-Term Increased Dietary Fructose
Gatto, C., Porzio, A. D., Crescenzo, R., Barrella, V., Iossa, S., & Mazzoli, A. (2023) · Antioxidants · doi:10.3390/antiox12020299 · Cited by 5
Shibata, M., Fukuda, S., Terasaki, M., & Maeda, H. (2024) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2023.1331061 · Cited by 5
Anggreini, P., Kuncoro, H., Sumiwi, S. A., & Levita, J. (2024) · Journal of Experimental Pharmacology · doi:10.2147/jep.s473763 · Cited by 5
Duan, S., Tu, Z., Duan, L., & Tu, R. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03557-5 · Cited by 5
Mapfumo, M., Lembede, B. W., Nkomozepi, P., Ndhlala, A. R., & Chivandi, E. (2019) · South African Journal of Botany · doi:10.1016/j.sajb.2019.05.026 · Cited by 6
Sweet Beverages and Cancer: A Scoping Review of Quantitative Studies
Yeary, K. H.-C. K., Quisenberry, A. J., Hall, M. G., Yu, H., Henry, W. A. E., Rodriguez, E. M., & Zoellner, J. M. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0507 · Cited by 5
Boonloh, K., Thanaruksa, R., Proongkhong, T., Thawornchinsombut, S., & Pannangpetch, P. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.k.0170 · Cited by 5
Qiao, T., Xi, J., Cao, Y., He, R., Zhao, Y., Shao, Y., Pan, X., Huang, J., Chen, Y., & Zhuang, R. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/9952583 · Cited by 5
Relative Recovery of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Rats
Aboujassoum, H., Mohamed‐Ali, V., Abraham, D., Clapp, L. H., & Al‐Naemi, H. A. (2023) · Nutrients · doi:10.3390/nu16010115 · Cited by 7
Exercise, mTOR Activation, and Potential Impacts on the Liver in Rodents
Onaka, G. M., de Carvalho, M. R., Onaka, P. K., Barbosa, C. M., Martinez, P. F., & de Oliveira-Junior, S. A. (2024) · Biology · doi:10.3390/biology13060362 · Cited by 6
Knockdown of RASD1 improves MASLD progression by inhibiting the PI3K/AKT/mTOR pathway
Zeng, G., Liu, X., Zheng, Z., Zhao, J., Zhuo, W., Bai, Z., Lin, E., Cai, S., Cai, C., Li, P., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02419-z · Cited by 5
Modeling fructose-load-induced hepatic de-novo lipogenesis by model simplification
Allen, R., & Musante, C. J. (2017) · Gene Regulation and Systems Biology · doi:10.1177/1177625017690133 · Cited by 5
Özkan, H., Kutlu, T., Yakan, A., & Özsoy, Ş. Y. (2021) · Ankara Üniversitesi Veteriner Fakültesi Dergisi · doi:10.33988/auvfd.855124 · Cited by 5
Non-cardiometabolic comorbidities of non-alcoholic fatty liver disease
Milaciu, M. V., Hațieganu", I., Ciumărnean, L., Sâmpelean, D., Negrean, V., Milaciu, C., & Acalovschi, M. (2018) · Balneo Research Journal · doi:10.12680/balneo.2018.170 · Cited by 5
Al-Muzafar, H. M., & Amin, K. A. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6563 · Cited by 5
Molecular alterations induced by fructose and its impact on metabolic diseases
Loza-Medrano, S. S., Baiza-Gutman, L. A., Ibáñez-Hernández, M. Á., Cruz, M., & Díaz-Flores, M. (2019) · PubMed · Cited by 5
Ohashi, K., Ohta, Y., Ishikawa, H., & Kitagawa, A. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-48 · Cited by 5
Epidemiology and Comorbidities
Mathus-Vliegen, E. M. H., & Dargent, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90074-2_1 · Cited by 5
Andrés-Hernando, A., Orlicky, D. J., Kuwabara, M., Fini, M. A., Tolan, D. R., Johnson, R. J., & Lanaspa, M. A. (2024) · Communications Biology · doi:10.1038/s42003-024-06539-1 · Cited by 4
The battle over “food addiction”
Lustig, R. H. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1621742 · Cited by 4
Tatoli, R., Bonfiglio, C., Donghia, R., Pesole, P. L., Fontana, L., & Giannelli, G. (2025) · Nutrients · doi:10.3390/nu17213372 · Cited by 5
Chen, H., Ye, Y., He, T., Li, B., & Wang, Q. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02105-3 · Cited by 5
Establishment and metabonomics analysis of nonalcoholic fatty liver disease model in golden hamster
Zhao, C.-Z., Jiang, L., Li, W., Wu, G., Chen, J., Dong, L.-H., Li, M., Jiang, W., Zhu, J.-X., Gao, Y., et al. (2022) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2021-0201 · Cited by 5
Li, P., Wang, T., Qiu, H., Zhang, R., Yu, C., & Wang, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011289 · Cited by 7
Barbier‐Torres, L., Luque-Urbano, M. R., Chhimwal, J., Robinson, A., Fernández‐Ramos, D., Lopitz‐Otsoa, F., Eyk, J. E. V., Millet, Ó., Mato, J. M., & Lu, S. C.-L. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156154 · Cited by 4
Strober, J. W., Siebel, S., Murray, S. F., Rodríguez, M. G., Gonzalez, C. R.-N., & Vatner, D. F. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100838 · Cited by 4
Palavicini, J. P., & Han, X. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00018-4 · Cited by 4
Inflammatory Biomarkers in Nutrition
Abreu, S., & Sousa‐Pimenta, M. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-07389-2_44 · Cited by 4
CD38 Inhibition Protects Fructose-Induced Toxicity in Primary Hepatocytes
Lee, S. H., Choi, S., Park, S., Hwang, Y., Son, Y., & KANG, Y. Y. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0045 · Cited by 5
Xiao, S., Chen, Z., Mai, T., Cai, J., Chen, Y., Tang, X., Gou, R., Luo, T., He, K., Li, T., et al. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02864-7 · Cited by 4
Effects of Excessive High-fructose Corn Syrup Drink Intake in Middle-aged Mice
HIDAKA, M., OSHIMA, Y., Hanai, Y., Kataoka, H., & Hattori, H. (2024) · In Vivo · doi:10.21873/invivo.13550 · Cited by 4
Ding, Z., Zhang, J., & Choudhury, M. (2024) · Life · doi:10.3390/life14060729 · Cited by 4
Sun, H., Zhang, Y., Ren, T., Gao, Q., Shi, X., Li, X., Zhang, P., Li, Z., & Liu, H. (2024) · Animals · doi:10.3390/ani14121781 · Cited by 4
Leya, M., Jeong, H., Yang, D., Bao, T. H. T. N., Pandeya, P. R., Oh, S.-I., Roh, Y., Kim, J.-W., & Kim, B. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.08.003 · Cited by 4
Cai, Y., & Chen, Q. (2024) · Phytotherapy Research · doi:10.1002/ptr.8416 · Cited by 4
Wang, J., Du, M.-M., Du, Y., & Li, J. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174838 · Cited by 4
Kawashima, Y., Eguchi, Y., Yamazaki, T., Karahashi, M., Kawai, H. F., & Kudo, N. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.246165 · Cited by 4
Dietary fructose intake is correlated with fat distribution in the Newfoundland population
Sheng, H., Zhang, H., Zhang, W., & Sun, G. (2021) · Nutrition · doi:10.1016/j.nut.2021.111434 · Cited by 5
Eslami, Z., Mirghani, S. J., Moghanlou, A. E., Norouzi, A., Naseh, H., Joshaghani, H., Peres, W. A. F., Younesian, O., Hosseinzadeh, S., & Bideskan, J. A. (2021) · Hepatitis Monthly · doi:10.5812/hepatmon.117696 · Cited by 5
Jeyakumar, S., & Vajreswari, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00030-6 · Cited by 4
Lee, H., Cho, S., Kang, A., Shin, D., Park, H.-Y., & Jeong, T. (2021) · Life · doi:10.3390/life11070645 · Cited by 4
Exploration of Digestive Diseases
(2022) · Exploration of Digestive Diseases · doi:10.37349/edd · Cited by 4
Fructose Metabolism and Metabolic Dysfunction in Adolescents and Young Adults
Softic, S., Lanaspa, M. A., & DeBosch, B. J. (2023) · Nutrients · doi:10.3390/nu15143162 · Cited by 4
Self-citationShao, C.-H., Wayal, V., & Hsieh, C. (2025) · Nutrients · doi:10.3390/nu17122011 · Cited by 3
Yu, J., Zhu, H., Yu, X., Liu, Y., Zhang, J., Jiang, L., & Zhang, X. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110017 · Cited by 3
Verhoeven, A., Sanz-Serrano, J., & Vinken, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04235-5 · Cited by 4
Besné-Eseverri, I., Benito, D., Fisico-Echezarraga, M., Arán‐González, M., Cano, M. P., Portillo, M. P., & Trepiana, J. (2026) · Nutrients · doi:10.3390/nu18030420 · Cited by 3
Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches
Cigliano, A., Pischedda, D., Pandino, C., Galleri, G., & Calvisi, D. F. (2026) · Biomolecules · doi:10.3390/biom16020329 · Cited by 3
Shakerian, E., Yaghooti, H., Kheirollah, A., & Mohammadtaghvaei, N. (2022) · Immunopathologia Persa · doi:10.34172/ipp.2022.29268 · Cited by 3
Luján, L. M. L., McCarty, M. F., Galvez-Ruiz, J. C., López, S. T., & Assanga, S. B. I. (2024) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2024.200281 · Cited by 2
Narimatsu, Y., Kato, M., Ukena, K., Furumitsu, M., & Ukena, K. (2025) · Peptides · doi:10.1016/j.peptides.2025.171376 · Cited by 3
Singh, V., Chattopadhyay, P., Fatima, F., Singh, P., Pandey, R., Agrawal, A., & Roy, S. S. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167886 · Cited by 3
Jin, M., Zhang, R., Xin, W., Sun, L., Fan, X. Q., Lü, Q., Zhang, L., Jiang, Z., & Yu, Q. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100047 · Cited by 3
The main approaches to dietary changes in non-alcoholic fatty liver disease
Drapkina, O. M., Шепель, Р. Н., Starodubova, A. V., & Evsutina, Y. V. (2018) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20182106178 · Cited by 3
Liquid fructose and liver insulin signaling: Molecular mechanisms controlling hepatic steatosis
Sangüesa, G., Roglans, N., Laguna, J. C., & Alegret, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-849886-6.00004-5 · Cited by 3
Nonalcoholic liver disease: review with a focus on risks of progression
Teplyuk, D. A., Semenistaya, M. C., Sorokoletov, S. M., Лазебник, Л. Б., & Pavlov, C. S. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-192-8-167-174 · Cited by 3
Metadata
- Authors
- Softic, S., Cohen, D. E., & Kahn, C. R.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Kahn, C. Ronald
- Venue
- Digestive Diseases and Sciences
- Published
- 2016-02-08
- Volume
- 61
- Issue
- 5
- Pages
- 1282-1293
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- PMC
- PMC4838515
- OpenAlex
- W2286797029
- Cited by
- 709
- References
- 133
- Citations by year
- 2026: 52 · 2025: 76 · 2024: 88 · 2023: 78 · 2022: 92 · 2021: 79 · 2020: 88 · 2019: 57 · 2018: 44 · 2017: 42 · 2016: 13
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK031036, R01 DK033201, K12 HD000850, R37 DK048873, R01 DK056626, R01 DK103046)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, dietary fructose, hepatic de novo lipogenesis, high fructose corn syrup, high-fat diet, sugar-sweetened beverages, insulin resistance, SREBP-1c, endoplasmic reticulum stress, uric acid, mitochondrial fatty acid oxidation, reactive oxygen species, hepatic lipid metabolism, metabolic syndrome
- MeSH terms
- Diet, Fructose, Humans, Liver, Lipogenesis, Non-alcoholic Fatty Liver Disease, High Fructose Corn Syrup
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review